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INSTRUCTIONS FOR AUTHORS
Thank you for your interest in Annals of Translational 
Medicine (ATM). Please consult the following instructions 
to help you prepare your manuscript, and feel free to 
contact us with any questions. To ensure fast peer review 
and publication, manuscripts that do not adhere to the 
following instructions will be returned to the corresponding 
author for technical revision before undergoing peer review. 
We are looking forward to your submission.
1. ABOUT THE JOURNAL
The Annals of Translational Medicine (Ann Transl Med; 
ATM; Print ISSN 2305-5839; Online ISSN 2305-5847) 
is an international, peer-reviewed Open Access journal 
featuring original and observational investigations in 
the broad fields of laboratory, clinical, and public health 
research, aiming to provide practical up-to-date information 
in significant research from all subspecialties of medicine. 
It is published quarterly (April 2013- Dec 2013), monthly 
(Jan 2014 - Dec 2014), biweekly (March 2015-) and openly 
distributed worldwide.
Specific areas of interest include, but not limited to, 
multimodality therapy, epidemiology, biomarkers, imaging, 
biology, pathology, and technical advances related to 
medicine. Submissions describing preclinical research with 
potential for application to human disease, and studies 
describing research obtained from preliminary human 
experimentation with potential to further the understanding 
of biological mechanism underlying disease are encouraged. 
Also warmly welcome are studies describing public 
health research pertinent to clinic, disease diagnosis and 
prevention, or healthcare policy.
Annals of Translational Medicine is indexed in PubMed. 
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Society for Translational Medicine (STM) and is endorsed 
by the Bonnie J. Addario Lung Cancer Foundation (ALCF).
2. MANUSCRIPT CATEGORIES
Original Articles
Original scientific reports of clinical research. Original 
articles should normally be in the format of Background, 
Methods, Results and Conclusions. Originality and clinical 
impact are essential for acceptance of Original Articles.
Word limit: 6,000 words maximum including abstract 
but excluding references, tables and figures.
Abstract: 300 words maximum, with sub-headers. 
Abstract should contain the following subheadings: 
Background, Methods, Results and Conclusions. There 
should be no subheaders, figures, tables, or references in the 
abstract.
References: no limit.
Keywords: 3 to 5.
Running title: less than 60 characters.
Figures/ tables: no limit.
Description: Full-length reports of current research in
either basic or clinical science.
Original article should entail a section describing the 
contribution each author made to the manuscript. See 
section “Authors’ Contribution” for details.
Review Articles 
Reviews are comprehensive analyses of specific topics. They 
are submitted upon invitation by the Editors. Proposals for 
reviews may be submitted; however, in this case authors 
should only send an outline of the proposed paper for initial 
consideration. Both solicited and unsolicited review articles 
will undergo peer review prior to acceptance. The text is 
limited to 5000 words excluding the title page, abstract, 
text, references, figures, figure legends, and tables. Abstracts 
are limited to 300 words.
Review Article should entail a section describing the 
contribution each author made to the manuscript. See 
section “Authors’ Contribution” for details.
Systematic Reviews and Meta-analysis
A comprehensive, scholarly, balanced, systematic review 
of evidence-based literature including all findings; these 
are not opinion submissions. Submissions should be state- 
of-the-art science confined mostly to the best available 
evidence. All meta-analyses of randomized trials must 
adhere to the guidelines outlined in the PRISMA statement, 
designed to improve manuscript quality. Authors must 
include a suitable PRISMA flow chart in their submission. 
Further advice on suitability is available from the Editorial 
Office.
The review must be no more than 6000 words, excluding 
title page, abstract, text, tables, figures, figure legends, and 
references. Structured abstract is limited to 300 words. 
The abstract should contain the following subheadings: 
Background, Methods, Results and Conclusions.
Systematic Reviews and Meta-analysis should entail a 
section describing the contribution each author made to the 
manuscript. See section “Authors’ Contribution” for details.
Research Highlights 
Research Highlights are ‘digest’ of the best/most interesting 
research findings that have been recently published in the 
field of cancer research. They are usually solicited by editors 
and written by outstanding experts. The text is limited to 
1500 words. No abstracts are required.
Technical Notes
Technical notes should present a novel or improved 
technique, investigation or procedure. The article must 
describe a demonstrable advance on what is currently 
available. The text is limited to 2500 words including 
abstract, but excluding references, tables and figures. 
Photos, drawings and videos are encouraged.
Commentaries 
Word Limit: 1500 words maximum excluding references, 
tables and figures.
Abstract: Not required.
References: 20 maximum, including the article discussed.
Figures/tables: 2 maximum.
Description: Commentary, upon Editor’s invitation, 
discusses a paper or report or event within the past few 
months or so, or in the near future. It should set the 
problems addressed by the paper/report/event in the wider 
context of the field. Proposals for Commentary may be 
submitted; however, in this case authors should only send 
an outline of the proposed paper for initial consideration.
Perspectives
Word limit: 3000 words maximum including abstract but 
excluding references, tables and figures.
Abstract: Unstructured. 300 words maximum.
References: no maximum.
Description: Perspectives can be more personal, forward-
looking or speculative, compared with reviews of a scientific 
topic. A paper presenting controversial positions or papers 
of the same topic advocate opposite sides will be published 
as Perspectives. Most of Perspectives will be solicited by 
the editors; however, we also welcome timely, unsolicited 
Perspectives. Proposals for perspectives may be submitted; 
however, in this case authors should send an outline of the 
proposed article prior to submission.
Editorials
Word Limit: 2,500 words maximum excluding references, 
tables and figures.
Abstract: Not required.
References: 25 maximum.
Figures/tables: 2 maximum.
Description: Editorial is written by recognized leader(s) in 
the field. It is generally solicited by the (Deputy) Editor(s)-
in-Chief.
Viewpoint
Word limit: 1200 words maximum excluding references, 
tables and figures.
Abstract: Not required.
References: 10 maximum.
Figures/tables: Only one table or figure.
Description: Viewpoints may address virtually any 
important topic in medicine, public health, research, ethics, 
health policy, or health law and generally are not linked 
to a specific article. Viewpoints should be well focused, 
scholarly, and clearly presented and must have no more than 
3 authors. 
Correspondence
Word limit: 1000 words maximum excluding references, 
tables and figures.
Abstract: Not required.
References: Not more than 10.
Figures/tables: Only one table or figure.
Description: Correspondence on content published in 
the Journal or on other topics of interest to our readers 
is welcomed. The journal might invite replies from the 
authors of the original publication, or pass on letters to 
these authors.
Study Protocols 
Study Protocols report planned or ongoing trials, describing 
the rationale, criteria, treatment plan, and anticipating the 
results. Since this type of article discusses an ongoing or 
planned trial, manuscripts that report work already carried 
out will not be considered as protocols, and conclusive data 
regarding outcomes should not be included.
The format of a Study Protocol may follow a format 
similar to an Original Article. It should contain the 
following sections: 
Title with specific study type, for example, a randomised 
controlled trial Structured Abstract, with Introduction, 
Methods and analysis, Discussion included. 
Registration details should be included as a final section, 
if appropriate.
The dates of study should be stated in the manuscript 
Ethical approval. Protocols for studies that will require 
ethical approval, such as trials, are unlikely to be considered 
without having received that approval.
Full references. 
Authors’ contributions (see Authors’ contributions part 
for details).
Funding statement.
Conflict of interests statement.
ATM Lecture Series
This is a 20-minute PowerPoint presentation with voiceover 
recording on a focused topic, given by an expert in the field. 
This section requires a 1500-word mini-review or an editorial 
to be submitted together with the Keynote Lecture file.
Surgical Techniques
“Surgical Techniques” is a featured section that publishes 
illustrated articles. These articles must include four 
subheadings—Abstract, Introduction, Operative Techniques 
and Comments. The abstract is limited to 300 words. The 
body of the article should include 10-15 medical drawings 
or photos, accompanied by detailed legends, describing 
the operative procedures in a step-by-step format. Expert 
opinions regarding possible pitfalls and the comparison 
of the described procedure with other methods are 
encouraged. It is important to submit (1) the outline of your 
manuscript and (2) the attached graphics by the submission 
date. Illustrations in color are encouraged and the finalized 
graphics submitted will be printed at no cost to the authors. 
If required, our medical illustrator may be made available, 
however, there will be additional costs associated with the 
use of this service.
Visualized Surgery
“Visualized Surgery” is a featured section that publishes 
narrated videos provided by renowned surgeons. This 
section is designed to be presented as a detailed “how to” 
multimedia manual for operative procedures. The submitted 
videos of each article must have a maximal limit of one hour 
in duration and it must be accompanied with descriptive 
text. The text should include four subheadings – Abstracts, 
Introduction, Operative Techniques and Comments. The 
abstract is limited to 300 words. The main section on 
Operative Techniques should include detailed descriptions 
of the procedures in a step-by-step format. Expert opinions 
regarding possible pitfalls and the comparison of the 
described procedure with other methods are encouraged. 
The corresponding author must confirm in the Copyright 
Transfer Agreement, that he/she has received a signed release 
form from each patient recorded on the submitted video. 
Ideally, patients should not be identifiable in these videos. 
Prior to publication and distribution, the ATM reserves the 
right to edit the submitted video, including the insertion 
of a voice-over. If required, additional video editing by the 
authors (which may delay publication) may also be requested.
Case Reports
Only cases of exceptional interest and novelty are 
considered. 
Word limit: 2,500 words maximum excluding references, 
tables and figures. 
Abstract: 300 words maximum, unstructured (no use of sub 
headers). 
References: 20 maximum. 
Figures/ tables: 8 maximum. 
Description: New observations of diseases, clinical findings 
or novel/unique treatment outcomes. The text should 
be arranged as follows: Introduction, Case Presentation, 
Discussion. 
The authors should provide a statement at the end of the 
main text to confirm that the patient has given their consent 
for the Case reports to be published. The editorial office may 
request copies of the informed consent documentation at any 
time. We recommend the following wording is used for the 
consent section: “Written informed consent was obtained 
from the patient for publication of this Case report and 
any accompanying images. A copy of the written consent is 
available for review by the Editor-in-Chief of this journal.”
If the patient has died, then consent for publication must 
be sought from the next of kin of the patient. If the patient 
is a minor, or unable to provide consent, then consent must 
be sought from the parents or legal guardians of the patient. 
In these cases, the statement in the ‘Consent’ section of the 
manuscript should be amended accordingly.
Only cases of exceptional interest and novelty are 
considered. For manuscripts that do not qualify, Editors 
may ask authors to shorten manuscripts and rewrite as 
Letters to the Editor.
3. STRUCTURE OF THE MANUSCRIPT 
The length of manuscripts must adhere to the specifications 
under the section Manuscript Categories.
Manuscripts should be presented in the following 
order: (i) title page, (ii) abstract and key words, (iii) text, 
(iv) acknowledgments, (v) footnote, (vi) references, (vii) 
supplementary material, (viii) figure legends, (ix) tables 
(each table complete with title and footnotes) and (x) 
figures. Footnotes to the text are not allowed and any 
such material should be incorporated into the text as 
parenthetical matter.
Key words and running title are required for all types of 
article. 
Title Page
The title page should contain (i) the title of the manuscript. 
Authors should include all information in the title that 
will make electronic retrieval of the article both sensitive 
and specific. (ii) the full names of the authors and (iii) the 
addresses of the institutions at which the work was carried 
out together with (iv) the full postal and email address, 
plus facsimile and telephone numbers of the corresponding 
author. The present address of any author, if different from 
that where the work was carried out, should be supplied 
in a footnote. In keeping with the latest guidelines of the 
International Committee of Medical Journal Editors, each 
author’s contribution to the paper is to be quantified. The 
title should be short, informative and contain the major 
key words so that readers and in particular online users 
will discover the article easily in online search. Do not use 
abbreviations in the title. A short running title (less than 40 
characters) should also be provided.
Abstract and Keywords
The length of abstracts must adhere to the word count 
specifications under the section Manuscript Categories. 
The abstract should include the following subheadings: 
Background, Methods, Results and Conclusions. It must be 
factual and comprehensive. The use of abbreviations and 
acronyms should be limited and general statements (e.g. ‘‘the 
significance of the results is discussed’’) should be avoided.
Three to five key words should be supplied below 
the abstract, in alphabetical order, and should be taken 
from those recommended by the US National Library of 
Medicine’s Medical Subject Headings (MeSH) browser list 
at: http://www.nlm.nih.gov/mesh/meshhome.html.
Text
Authors must use the following subheadings to divide the 
sections of their Original Article manuscript: Background, 
Methods, Results and Conclusions, Acknowledgment, 
Footnote, References, and when relevant, Supplementary 
Material. However, review, perspective, opinion and 
commentary articles do not require these specifically 
outlined sections, and they can be written in several sections 
with their own headings, as suitable. 
Authors’ Contribution
This section is required for original article, review article, 
systematic review and meta-analysis article and Clinical 
Guideline. It describes the contribution each author made 
to the manuscript. Authorship credit should be based on 
1) substantial contributions to conception and design, 
acquisition of data, or analysis and interpretation of data; 
2) drafting the article or revising it critically for important 
intellectual content; and 3) final approval of the version 
to be published. 4) Agreement to be accountable for all 
aspects of the work in ensuring that questions related 
to the accuracy or integrity of any part of the work are 
appropriately investigated and resolved. Authors should 
meet conditions 1, 2, 3, and 4, and all who meet the four 
criteria should be identified as authors. Those who do 
not meet all four criteria should be acknowledged (see 
section “Acknowledgement”). Please note that acquisition 
of funding, collection of data, language editing or general 
supervision of the research group alone does not constitute 
authorship.
The “Author Contributions” section should be completed 
as follow:
(1) Conception and design:
(2) Administrative support:
(3) Provision of study materials or patients:
(4) Collection and assembly of data:
(5) Data analysis and interpretation:
(6) Manuscript writing: All authors.
(7) Final approval of manuscript: All authors.
Note: 1. Manuscript writing part and Final approval of 
manuscript part are required to be included while other 
parts are based on actual applicability; 2. Contribution is 
not required when there is only one author. The authorship 
policy is consistent with criteria from the International 
Committee of Medical Journal Editors (ICMJE) (see section 
“AUTHORS’ RESPONSIBILITY AND CONFLICT OF 
INTEREST FORM”).
Example
M.M.M. designed the overall study with contributions from 
S.F. S.F. designed and carried out experiments, collected 
and analyzed data, and cowrote the paper. Y.S. designed 
and carried out experiments and collected and analyzed 
data with S.F. and M.M.M. S.B. carried out experiments, 
adapted the rapid TALEN assembly protocol, and analyzed 
data with Y.S. M.S.W. and M.M.M. designed the vector 
for the repair experiment. M.S.W. constructed the repair 
vector. S.F. and Y.S. carried out the repair experiment. 
S.F., Y.S., M.S.W., and M.M.M. discussed and edited 
the paper. M.M.M. supervised this study, designed and 
performed experiments, analyzed data, and and wrote the 
paper. (Cited from: Fanucchi S, Shibayama Y, Burd S, et 
al. Chromosomal contact permits transcription between 
coregulated genes. Cell 2013;155:606-20.) wrote the 
paper. (Cited from: Fanucchi S, Shibayama Y, Burd S, et 
al. Chromosomal contact permits transcription between 
coregulated genes.5Cell 2013;155:606-20.)
Acknowledgements
Textual material that names the parties which the author 
wishes to thank or recognize for their assistance in, for 
example, producing the work, funding the work, inspiring 
the work, or assisting in the research on which the work is 
based.
All contributors who do not meet the criteria for 
authorship should be listed in an acknowledgments section. 
Examples of those who might be acknowledged include 
a person who provided purely technical help, writing or 
language editing assistance, or a department chairperson 
who provided only general support. Financial and material 
support should also be acknowledged. When there is no 
one to be acknowledged, authors should also indicate 
‘Acknowledgements’ section as ‘None’.
ATM policy requires that all authors of all manuscripts 
sign a statement revealing: 1) Any financial interest in or 
arrangement with a company whose product was used 
in a study or is referred to in an article, 2) Any financial 
interest in or arrangement with a competing company, 3) 
Any other financial connections, direct or indirect, or other 
situations that might raise the question of bias in the work 
reported or the conclusions, implications or opinions stated 
including pertinent commercial, governmental, private or 
other sources of funding for the individual author(s) or for 
the affiliated department(s) or organization(s), personal 
relationships, or direct academic competition. Statements 
related to study design, such as providers of the drugs used 
in the study should be indicated in the Methods section 
of the article, and other financial interests which are not 
directly related to carrying out the study should be stated in 
the Acknowledgements.
Funding
Details of all funding sources for the work in question 
should be included in the Acknowledgement section.
The following rules should be followed:
The sentence should begin: ‘This work was supported by ...’.
The full official funding agency name should be given, 
i.e. ‘National Institutes of Health’, not ‘NIH’ (full RIN-
approved list of UK funding agencies) Grant numbers 
should be given in brackets as follows: ‘[grant number 
xxxx]’.
Multiple grant numbers should be separated by a comma 
as follows: ‘[grant numbers xxxx, yyyy]’.
Agencies should be separated by a semi-colon (plus ‘and’ 
before the last funding agency).
Where individuals need to be specified for certain 
sources of funding the following text should be added after 
the relevant agency or grant number ‘to [author initials]’.
An example is given here: ‘This work was supported 
by the National Institutes of Health [AA246897 to C.S., 
BB916391 to M.H.]; and the Interstitial Cystitis Association 
(ICA) Pilot Grant.
References
The Vancouver system of referencing should be used. In the 
text, references should be identified using numbers in round 
brackets in which they appear consecutively [e.g., “causing 
most BC deaths (1)”; “MIBC are greatly needed (6-8)”]. 
Number references consecutively in the order in which they 
are first mentioned in the text. The titles of journals should 
be abbreviated according to the style used in Index Medicus.
List all authors, but if the number exceeds three, give three 
followed by “et al.”
Resnick MJ, Bassett JC, Clark PE. Management of 
superficial and muscle-invasive urothelial cancers of the 
bladder. Curr Opin Oncol 2013;25:281-8.
For other styles of publication or Internet articles, see 
http://www.nlm.nih.gov/bsd/uniform_requirements.html
Tables
Tables should be self-contained and complement (but 
not duplicate) information contained in the text. Number 
tables consecutively in the text in Arabic numerals. Type 
tables on a separate page with the legend above. Legends 
should be concise but comprehensive – the table, legend 
and footnotes must be understandable without reference 
to the text. Vertical lines should not be used to separate 
columns. Column headings should be brief, with units of 
measurement in parentheses; all abbreviations must be 
defined in footnotes. Footnote symbols: †, ‡, §, ¶, should 
be used (in that order) and *, **, *** should be reserved for 
p-values. Statistical measures such as SD or SEM should be 
identified in the headings. If tables have been reproduced 
from another source, a letter from the copyright holder 
(usually the Publisher), stating authorization to reproduce 
the material, must be attached to the covering letter.
Figures
All illustrations (line drawings and photographs) are 
classified as figures. Figures should be cited in consecutive 
order in the text. Magnifications should be indicated 
using a scale bar on the illustration. If figures have 
been reproduced from another source, a letter from 
the copyright holder (usually the Publisher), stating 
authorization to reproduce the material, must be attached 
to the covering letter.
- Size: Figures should be sized to fit within the column 
(82 mm), intermediate (118 mm) or the full text width 
(173 mm). 
- Resolution:  Figures must be supplied as high 
resolution saved as .eps or .tif. Halftone figures 300 dpi 
(dots per inch), Color figures 300 dpi saved as CMYK, 
figures containing text 400 dpi, Line figures 1000 dpi. 
- Color figures: Files should be set up as CMYK (cyan, 
magenta, yellow, black) and not as RGB (red, green, blue) 
so that colors as they appear on screen will be a closer 
representation of how they will print in the ATM.
- Line figures: Must be sharp, black and white graphs or 
diagrams, drawn professionally or with a computer graphics 
package. 
- Text sizing in figures: Lettering must be included and 
should be sized to be no larger than the journal text or 8 
point (Should be readable after reduction – avoid large type 
or thick lines). Line width between 0.5 and 1 point.
- Figure legends: Type figure legends on a separate 
page. Legends should be concise but comprehensive – 
the figure and its legend must be understandable without 
reference to the text. Include definitions of any symbols 
used and define/explain all abbreviations and units of 
measurement.
Equations
Equations should be numbered sequentially with Arabic 
numerals; these should be ranged right in parentheses. All 
variables should appear in italics. Use the simplest possible 
form for all mathematical symbols.
4. FOOTNOTE
a. Conflicts of Interest: See section “Conflict of interest” for 
details.
b. Financial Disclose: Some variables, such as “measures of 
income inequality and degree of financial openness, are not 
included in our study because of the limited availability of 
good-quality data across countries over the sample period”.
5. ETHICAL CONSIDERATIONS
Authors must state that the protocol for the research 
project has been approved by a suitably constituted Ethics 
Committee of the institution within which the work was 
undertaken and that it conforms to the provisions of the 
Declaration of Helsinki (as revised in Edinburgh 2000), 
available at: http://www.wma.net/e/policy/b3.htm. The 
Annals retains the right to reject any manuscript on the 
basis of unethical conduct of either human or animal 
studies. All investigations on human subjects must include 
a statement that the subject gave informed consent. Patient 
anonymity should be preserved. Photographs need to 
be cropped sufficiently to prevent human subjects being 
recognized (or an eye bar should be used).
In general, submission of a case report should be 
accompanied by the written consent of the subject (or 
parent/guardian) before publication; this is particularly 
important where photographs are to be used or in cases 
where the unique nature of the incident reported makes it 
possible for the patient to be identified. While the Editorial 
Board recognizes that it might not always be possible 
or appropriate to seek such consent, the onus will be on 
the authors to demonstrate that this exception applies in 
their case. Any experiments involving animals must be 
demonstrated to be ethically acceptable and where relevant 
conform to national guidelines for animal usage in research.
6. CLINICAL TRIALS REGISTRY
We require, as a condition of consideration for publication, 
registration in a public trials registry. Trials must register at 
or before the onset of patient enrollment. This policy applies 
to any clinical trial starting enrollment after January 1, 2006. 
For trials that began enrollment before this date, we require 
registration by April 1, 2006, before considering the trial for 
publication. We define a clinical trial as any research project 
that prospectively assigns human subjects to intervention or 
comparison groups to study the cause-and-effect relationship 
between a medical intervention and a health outcome. Studies 
designed for other purposes, such as to study pharmacokinetics 
or major toxicity (e.g., phase 1 trials) are exempt.
We do not advocate one particular registry, but 
registration must be with a registry that meets the following 
minimum criteria: (1) accessible to the public at no 
charge; (2) searchable by standard, electronic (Internet-
based) methods; (3) open to all prospective registrants 
free of charge or at minimal cost; (4) validates registered 
information; (5) identifies trials with a unique number; and 
(6) includes information on the investigator(s), research 
question or hypothesis, methodology, intervention and 
comparisons, eligibility criteria, primary and secondary 
outcomes measured, date of registration, anticipated or 
actual start date, anticipated or actual date of last follow-up, 
target number of subjects, status (anticipated, ongoing or 
closed) and funding source(s).
Registries that currently meet these criteria include: (1) 
the registry sponsored by the United States National Library 
of Medicine (www.clinicaltrials.gov); (2) the International 
Standard Randomized Controlled Trial Number Registry 
(http://www.controlled-trials.com); (3) the Australian Clinical 
Trials Registry (http://www.actr.org.au); (4) the Chinese 
Clinical Trials Register (http://www.chictr.org); and (5) the 
Clinical Trials Registry - India (http://www.ctri.in).
7. RANDOMIZED CONTOLLED TRIALS
Reporting of randomized controlled trials should follow 
the guidelines of The CONSORT Statement: http://www.
consort-statement.org
8. COPYRIGHT
Papers accepted for publication in Annals of Translational 
Medicine (ATM) become copyright of ATM and the 
corresponding author will be asked to sign a transfer of 
copyright form on behalf of all authors. In signing the 
transfer of copyright, it is assumed that authors have 
obtained permission to use any copyrighted or previously 
published material. All authors must read and agree to the 
conditions outlined in the Copyright Assignment Form, 
and the corresponding author can sign on their behalf. 
Acceptance of a manuscript is contingent upon receipt of a 
signed Copyright Assignment Form. 
9. STYLE OF THE MANUSCRIPT
Manuscripts must follow the style of the Vancouver 
agreement detailed in the International Committee of 
Medical Journal Editors’ revised ‘Uniform Requirements 
for Manuscripts Submitted to Biomedical Journals: Writing 
and Editing for Biomedical Publication’, as presented at: 
http://www.ICMJE.org/.
Author name 
Each author’s given name should be followed by his/her 
surname. Capitalize each letter of the surname. A hyphen 
could be used in surname according to the rule in the 
Author’s region. Capitalize the first letter of those words/
syllables that they hope to be abbreviated in their given 
name, otherwise, DO NOT capitalize the first letter and 
use a hyphen to connect it with its anterior word.
Spelling 
The ATM uses US spelling and authors should therefore 
follow the latest edition of the Merriam–Webster’s 
Collegiate Dictionary.
Units 
All measurements must be given in SI or SI-derived units. 
For more information about SI units, please go to the 
Bureau International des Poids et Mesures (BIPM) website 
at: http://www.bipm.fr 
Abbreviations 
Must be used sparingly – only where they ease the reader’s 
task by reducing repetition of long, technical terms. Initially 
use the word in full, followed by the abbreviation in 
parentheses. Thereafter use the abbreviation only.
Trade names 
Drugs should be referred to by their generic names. If 
proprietary drugs have been used in the study, refer to these 
by their generic name, mentioning the proprietary name, and 
the name and location of the manufacturer, in parentheses.
10. APPENDIX
The Supplementary Appendix should be paginated, with 
a table of contents, followed by the list of investigators (if 
there is one), text (such as methods), figures, tables, and 
then references. The supplementary appendix should not be 
included in the article’s reference list.
The Appendix must be submitted in a Word file. The 
Appendix will not be edited for style. It will be presented 
online as additional information provided by the authors. 
The published article will contain a statement that 
supplementary material exists online and will provide the 
reader with a URL and link. To reference the supplementary 
appendix in the text of the article, refer to it as in the 
following example: 
“More data can be found in the article. The interested 
reader can read a supplementary appendix online.” 
11. SUBMISSION OF MANUSCRIPTS
Please make sure the publication ethics (www.atmjournal.
org/public/system/atm/atm-publication-ethics.pdf) are 
followed strictly before your submission.
Please note that change of author information (except 
for grammatical error) and retraction of manuscript are not 
allowed after the manuscript is accepted.
General Requirements
All articles submitted to the ATM must comply with these 
instructions. Failure to do so will result in return of the 
manuscript and possible delay in publication.
	Submissions must be double-spaced.
	All margins should be at least 30 mm.
	All pages should be numbered consecutively in the 
top right-hand corner, beginning with the title page.
	Do not use Enter at the end of lines within a paragraph.
	Turn the hyphenation option off; include only those 
hyphens that are essential to the meaning.
	Specify any special characters used to represent non-
keyboard characters.
	Take care not to use l (ell) for 1 (one), O (capital o) 
for 0 (zero) or ß (German esszett) for (Greek beta).
	Use a tab, not spaces, to separate data points in 
tables. If you use a table editor function, ensure that 
each data point is contained within a unique cell (i.e. 
do not use carriage returns within cells).
Each figure should be supplied as a separate file, with 
the figure number incorporated in the file name. For 
submission, low-resolution figures saved as .jpg or .bmp 
files should be uploaded, for ease of transmission during 
the review process. Upon acceptance of the article, high-
resolution figures (at least 300 dpi) saved as .eps or .tif files 
should be uploaded. Digital images supplied only as low-
resolution files cannot be used for publication.
Cover Letter
Papers are accepted for publication in ATM based on the 
understanding that the content has not been published or 
submitted for publication elsewhere except as a brief abstract 
in the proceedings of a scientific meeting or symposium. 
This must be stated in the covering letter. The covering 
letter must also contain an acknowledgment that all authors 
have contributed significantly, and that all authors are in 
agreement with the content of the manuscript. In keeping 
with the latest guidelines of the International Committee of 
Medical Journal Editors, each author’s contribution to the 
paper is to be quantified.
12. AUTHORS’ RESPONSIBILITY AND CONFLICT 
OF INTEREST FORM
Authors’ responsibility
We ask all authors to confirm that: 1) they have not 
previously published or have not submitted the same 
manuscript elsewhere, 2) they took a significant part in the 
work and approved the final version of the manuscript, 3) 
they have complied with ethical standards, 4) they agree 
AME publishing company, to get a licence to publish the 
accepted article when the manuscript is accepted, and 5) 
they have obtained all necessary permissions to publish 
any figures or tables in the manuscript, and assure that the 
authors will pay for Article Processing Charges (APC).
The ICMJE recommends that authorship be based on 
the following 4 criteria:
• Substantial contributions to the conception or design 
of the work; or the acquisition, analysis, or interpretation of 
data for the work; AND
• Drafting the work or revising it critically for important 
intellectual content; AND
• Final approval of the version to be published; AND
• Agreement to be accountable for all aspects of the 
work in ensuring that questions related to the accuracy 
5 or integrity of any part of the work are appropriately 
investigated and resolved.
All those designated as authors should meet all four 
criteria for authorship, and all who meet the four criteria 
should be identified as authors. Those who do not meet 
all four criteria should be acknowledged (see section 
“Acknowledgement”).
Conflict of interest
Our journal complies with the International Committee of 
Medical Journal Editors’ uniform requirements on Conflict 
of Interest statement.
Conflict of Interest exists when an author (or the author’s 
institution), reviewer, or editor has financial or personal 
relationships with other persons or organizations that 
inappropriately influence (bias) his or her actions. The 
existence of such relationships does not necessarily represent 
true conflict of interest. The potential for conflict of interest 
can exist whether or not an individual believes that the 
relationship affects their judgment. Financial relationships 
(such as employment, consultancies, stock ownership, 
honoraria, paid expert testimony, patents) are the most 
easily identifiable conflicts of interest and the most likely to 
undermine the credibility of the journal, the authors, and of 
science itself (http://www.icmje.org/index.html).
Confl ic t  of  interest  would be  inc luded in  the 
FOOTNOTE section.
(1) Participants
All participants in the peer-review and publication 
process—not only authors but also peer reviewers, editors, 
and editorial board members of journals—must consider 
their conflicts of interest when fulfilling their roles in the 
process of article review and publication and must disclose 
all relationships that could be viewed as potential conflicts 
of interest.
a. Authors
When authors submit a manuscript of any type or format 
they are responsible for disclosing all financial and personal 
relationships that might bias or be seen to bias their work. 
b. Peer Reviewers
Reviewers should be asked at the time they are asked to 
critique a manuscript if they have conflicts of interest that 
could complicate their review. Reviewers must disclose 
to editors any conflicts of interest that could bias their 
opinions of the manuscript, and should recuse themselves 
from reviewing specific manuscripts if the potential for 
bias exists. Reviewers must not use knowledge of the work 
they’re reviewing before its publication to further their own 
interests.
c. Editors and Journal Staff
Editors who make final decisions about manuscripts 
should recuse themselves from editorial decisions if 
they have conflicts of interest or relationships that pose 
potential conflicts related to articles under consideration. 
Other editorial staff members who participate in editorial 
decisions must provide editors with a current description 
of their financial interests or other conflicts (as they might 
relate to editorial judgments) and recuse themselves from 
any decisions in which a conflict of interest exists. Editorial 
staff must not use information gained through working with 
manuscripts for private gain. Editors should publish regular 
disclosure statements about potential conflicts of interests 
related to the commitments of journal staff. Guest editors 
should follow these same procedures. 
(2) Reporting Conflicts of Interest
Articles should be published with statements or supporting 
documents, declaring:
	Authors’ conflicts of interest; and
	Sources of support for the work, including sponsor 
names along with explanations of the role of those 
sources if any in study design; collection, analysis, 
and interpretation of data; writing of the report; the 
decision to submit the report for publication; or a 
statement declaring that the supporting source had 
no such involvement; and
	Whether the authors had access to the study data, 
with an explanation of the nature and extent of 
access, including whether access is on-going.
To support the above statements, editors may request 
that authors of a study sponsored by a funder with a 
proprietary or financial interest in the outcome sign a 
statement, such as “I had full access to all of the data in this 
study and I take complete responsibility for the integrity of 
the data and the accuracy of the data analysis.”
If there is conflict of interest for the authors, authors 
must state conflict of interest based on the actual condition; 
if there is no conflict of interest, state conflict of interest 
section as the following format: “The author has no 
conflicts of interest to declare” or “The authors have no 
conflicts of interest to declare”.
13. HUMAN AND ANIMAL RIGHTS, INFORMED 
CONSENT
When reporting experiments on human subjects, authors 
should indicate whether the procedures followed were in 
accordance with the ethical standards of the responsible 
committee on human experimentation (institutional and 
national). If doubt exists whether the research was conducted 
in accordance with the ethical standards, the authors must 
explain the rationale for their approach, and demonstrate that 
the institutional review body explicitly approved the doubtful 
aspects of the study. When reporting experiments on animals, 
authors should be asked to indicate whether the institutional 
and national guide for the care and use of laboratory animals 
was followed.
Editors should protect the confidentiality of individual 
information (e.g. that obtained through the doctor–patient 
relationship). It is therefore almost always necessary to obtain 
written informed consent from patients described in case 
reports and for photographs of patients. It may be possible 
to publish without explicit consent if the report is important 
to public health (or is in some other way important); consent 
would be unusually burdensome to obtain; and a reasonable 
individual would be unlikely to object to publication (all three 
conditions must be met).
14. REVIEW PROCESS
Manuscripts are assigned sequentially to Associate Editors. 
An Associate Editor solicits reviewers (typically, two external 
reviews are sought). The reviewers’ evaluations and Associate 
Editor’s comments are compiled by the Editor-in-Chief for 
disposition and transmittal to the authors. A decision is made 
usually within six weeks of the receipt of the manuscript.
The Editor-in-Chief will advise authors whether a 
manuscript is accepted, should be revised or is rejected. 
Minor revisions are expected to be returned within four 
weeks of decision; major revisions within three months. 
Manuscripts not revised within these time periods are 
subject to withdrawal from consideration for publication 
unless the authors can provide extenuating circumstances.
A number of manuscripts will have to be rejected on the 
grounds of priority and available space. A manuscript may 
be returned to the authors without outside review if the 
Editor-in-Chief and Associate Editor find it inappropriate 
for publication in the Journal. Similarly, the Editors may 
expedite the review process for manuscripts felt to be of 
high priority in order to reach a rapid decision. Such ‘fast-
track decisions’ will normally occur within one week of 
receipt of the manuscript. 
Authors may recommend preferred reviewers by 
providing the Editor-in-Chief with the names, addresses and 
email addresses of up to three suitably qualified individuals 
of international standing but the Editor-in-Chief will not 
be bound by any such nomination. Likewise, authors may 
advise of any individual who for any reason, such as potential 
conflict of interest, might be inappropriate to act as a referee, 
again without binding the Editor-in-Chief.
The Editor-in-Chief’s decision is final. If, however, authors 
dispute a decision and can document good reasons why a 
manuscript should be reconsidered, a rebuttal process exists. In 
the first place, authors should write to the Editor-in-Chief.
All journals Manuscripts should be written in a clear, 
concise, direct style so that they are intelligible to the 
professional reader who is not a specialist in the particular 
field. Where contributions are judged as acceptable for 
publication, the Editor and the Publisher reserve the right 
to modify manuscripts to eliminate ambiguity and repetition 
and improve communication between authors and readers. 
If extensive alterations are required, the manuscript will be 
returned to the author for revision.
15. PROOFS
It is essential that corresponding authors supply an email 
address to which correspondence can be emailed while 
their article is in production. Notification of the URL 
from where to download a Portable Document Format 
(PDF) typeset page proof, associated forms and further 
instructions will be sent by email to the corresponding 
author. The purpose of the PDF proof is a final check of 
the layout, and of tables and figures. Alterations other than 
the essential correction of errors are unacceptable at PDF 
proof stage. The proof should be checked, and approval to 
publish the article should be emailed to the Publisher by 
the date indicated, otherwise, it may be signed off by the 
Editor or held over to the next issue. Acrobat Reader will 
be required in order to read the PDF. This software can 
be downloaded (free of charge) from the following Web 
site: http://www.adobe.com/products/acrobat/readstep2.
html. This will enable the file to be opened, read on screen, 
and printed out in order for any corrections to be added. 
Further instructions will be sent with the proof.
16. OFFPRINTS
Minimum orders of 50 offprints will be provided upon request, 
at the author’s expense. Please email editor@atmjournal.org.
17. NO PUBLICATION FEES
There is no fee involved throughout the publication 
process. The acceptance of the article is based on the merit 
of quality of the manuscripts.
18. TRACKING MANUSCRIPTS
Author Services enables authors to track their article, once 
it has been accepted, through the production process to 
publication online and in print. Authors can check the status 
of their articles online and choose to receive automated 
emails at key stages of production so they do not need to 
contact the production editor to check on progress. 
19. EPUB AHEAD OF PRINT 
(ACCEPTED ARTICLES) 
ATM offers Accepted Articles service for selected articles. 
Accepted Articles are complete full-text articles published 
online in advance of their publication in a printed issue. 
Articles are therefore available as soon as they are ready, 
rather than having to wait for the next scheduled print issue. 
Accepted Articles have been fully reviewed and approved 
for publication, but has yet to undergo copy-editing and 
proof correction. They are therefore given a Digital Object 
Identifier (DOI), which allows the article to be cited 
and tracked before it is allocated to an issue. After print 
publication, the DOI remains valid and can continue to be 
used to cite and access the article. More information about 
DOIs can be found at http://www.doi.org/faq.html
20. ATM Online
For more information, visit the journal home page at: 
http://www.atmjournal.org/.
